Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 11/20 | 0.51 |
| ▸ | CDC25B | P30305 | 10/20 | 0.51 |
| ▸ | EBP | Q15125 | 5/20 | 0.50 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410405 | 1.00 | CDC25A (0.51) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL29398347 | 1.00 | CDC25A (0.51) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL332666 | 1.00 | CDC25A (0.51) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL14116734 | 0.87 | CDC25A (0.54) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL14034589 | 0.87 | CDC25A (0.54) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL28161748 | 0.85 | PTPN1 (0.44) | CDC25ACDC25BEBPNPC1L1PTPN1 | |
| SCHEMBL29364678 | 0.83 | CDC25A (0.50) | CDC25ACDC25BEBP | |
| SCHEMBL1470722 | 0.83 | EBP (0.48) | CDC25ACDC25BEBPNPC1L1MEN1 | |
| SCHEMBL1470720 | 0.83 | EBP (0.48) | CDC25ACDC25BEBPNPC1L1MEN1 | |
| SCHEMBL1470719 | 0.83 | EBP (0.48) | CDC25ACDC25BEBPNPC1L1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250338841-A1 | Dry Powdered Compositions and Methods and Uses Thereof | NEOZYME INTERNATIONAL, INC. (US) | 2025-11-06 | — | — | US | claimed |
| US-12356985-B2 | Dry powdered compositions and methods and uses thereof | NEOZYME INTERNATIONAL, INC. (US) | 2025-07-15 | — | — | US | claimed |
| US-20240334927-A1 | Dry Powdered Compositions and Methods and Uses Thereof | NEOZYME INTERNATIONAL, INC. (US) | 2024-10-10 | — | — | US | claimed |
| US-11911489-B2 | Saponin-containing compositions for use in textile wipes and methods of use and preparation | SANJEEVITA BY AUDUBON, LLC (US) | 2024-02-27 | — | — | US | claimed |
| EP-4142896-A1 | NON-TOXIC FIRE EXTINGUISHING COMPOSITIONS, DEVICES AND METHODS OF USING SAME | Neozyme Inernational, Inc. (US) | 2023-03-08 | — | — | EP | claimed |
| EP-4142522-A1 | DRY POWDERED COMPOSITIONS AND METHODS AND USES THEREOF | Neozyme Inernational, Inc. (US) | 2023-03-08 | — | — | EP | claimed |
| EP-4742891-A2 | METHOD OF GENOME-EDITING | Universiteit Gent (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4229019-B1 | BUILDING MATERIAL ADDITIVE FOR CEMENT-BASED BUILDING MATERIALS | ML7 ENTW GMBH (DE) | 2026-02-18 | — | — | EP | disclosed |
| US-20250338841-A1 | Dry Powdered Compositions and Methods and Uses Thereof | NEOZYME INTERNATIONAL, INC. (US) | 2025-11-06 | — | — | US | disclosed |
| EP-4043560-B1 | GROUP OF GLYCOSYLTRANSFERASES AND USE THEREOF | GSYNBIOT SHANGHAI CO LTD (CN) | 2025-08-13 | — | — | EP | disclosed |
| US-12356985-B2 | Dry powdered compositions and methods and uses thereof | NEOZYME INTERNATIONAL, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-20250099797-A1 | Non-Toxic Fire Extinguishing Compositions, Devices and Methods of Using Same | NEOZYME INTERNATIONAL, INC. (US) | 2025-03-27 | — | — | US | disclosed |
| EP-4499589-A1 | DRYING ACCELERATOR FOR CEMENT-BASED BUILDING MATERIALS | ML7 Entwicklungs GmbH (DE) | 2025-02-05 | — | — | EP | disclosed |
| EP-4142896-A1 | NON-TOXIC FIRE EXTINGUISHING COMPOSITIONS, DEVICES AND METHODS OF USING SAME | Neozyme Inernational, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| WO-2022192466-A1 | HERBAL EXTRACT FORMULA FOR TREATING CORONAVIRUS INFECTION | WAHI PHARMACEUTICALS INC. (US) | 2022-09-15 | — | — | WO | disclosed |
| EP-4043560-A2 | GROUP OF GLYCOSYLTRANSFERASES AND USE THEREOF | CAS Center for Excellence in Molecular Plant Sciences (CN) | 2022-08-17 | — | — | EP | disclosed |
| US-20220217934-A1 | CELLULOSE-SYNTHASE-LIKE ENZYMES AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-07-14 | — | — | US | disclosed |
| WO-2022079148-A1 | BUILDING MATERIAL ADDITIVE FOR CALCIUM SULPHATE-BASED BUILDING MATERIALS | ML7 ENTWICKLUNGS GMBH (DE) | 2022-04-21 | — | — | WO | disclosed |
| WO-2022079146-A1 | BUILDING MATERIAL ADDITIVE FOR CEMENT-BASED BUILDING MATERIALS | ML7 ENTWICKLUNGS GMBH (DE) | 2022-04-21 | — | — | WO | disclosed |
| EP-3985110-A1 | GROUP OF GLYCOSYLTRANSFERASES AND USE THEREOF | CAS Center for Excellence in Molecular Plant Sciences (CN) | 2022-04-20 | — | — | EP | disclosed |